机译:新型Indolizino [8,7-B]吲哚杂交物作为抗小细胞肺癌剂:拓扑异构酶II抑制和DNA交联活动的区域选择性调节
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Saurashtra Univ Dept Chem Rajkot Gujarat India;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Acad Sinica Inst Biomed Sci Taipei 11529 Taiwan;
Anti-SCLC hybrids; beta-carboline; bis(hydroxymethyl)pyrrole; indolizino8; 7-bindole; DNA cross-linking; Topoisomerase inhibition;
机译:新型Indolizino [8,7-B]吲哚杂交物作为抗小细胞肺癌剂:拓扑异构酶II抑制和DNA交联活动的区域选择性调节
机译:“用于治疗人非小细胞肺癌细胞的有效吲哚并[6,7-b]吲哚衍生物”更正[Neoplasia 18(2016)199-212]
机译:Indolizino的有效衍生物[6,7-B]吲哚,用于治疗人非小细胞肺癌细胞
机译:丝裂霉素C和其他DNA交联剂对基因表达的影响:细胞培养和体内癌细胞多药耐药性的调节。
机译:CoII-奎那利嗪的活性:A基于蒽环类抗癌药的新型类似物靶向人类DNA拓扑异构酶奎那利嗪本身通过形成起作用醌对急性淋巴细胞白血病MOLT-4和HCT的影响116细胞
机译:Indolizino [6,7-b]吲哚治疗人非小细胞肺癌细胞的强效衍生物